Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases

Altered intestinal microbial composition (dysbiosis) and metabolic products activate aggressive mucosal immune responses that mediate inflammatory bowel diseases (IBD). This dysbiosis impairs the function of regulatory immune cells, which normally promote mucosal homeostasis. Normalizing and maintai...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishima, Yoshiyuki, Sartor, Ryan Balfour
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942586/
https://www.ncbi.nlm.nih.gov/pubmed/31482438
http://dx.doi.org/10.1007/s00535-019-01618-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942586/
https://www.ncbi.nlm.nih.gov/pubmed/31482438
http://dx.doi.org/10.1007/s00535-019-01618-1

Ejemplares similares